In contrast, a tau-PET scan would not add prognostic information when evaluating annual MMSE change in the patients with SCD or MCI below the pTau217 cutoff (these patients would not be selected for tau-PET in our suggested workflow). This evidence concerns the gene MAPT and Schnyder corneal dystrophy.